Annual Current Liabilities
$22.81 M
+$7.78 M+51.72%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual total current liabilities is $22.81 million, with the most recent change of +$7.78 million (+51.72%) on April 30, 2024.
- During the last 3 years, KALV annual current liabilities has risen by +$13.03 million (+133.34%).
- KALV annual current liabilities is now -1.76% below its all-time high of $23.22 million, reached on April 30, 2018.
Performance
KALV Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$22.16 M
-$247.00 K-1.10%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly total current liabilities is $22.16 million, with the most recent change of -$247.00 thousand (-1.10%) on October 31, 2024.
- Over the past year, KALV quarterly current liabilities has dropped by -$643.00 thousand (-2.82%).
- KALV quarterly current liabilities is now -7.97% below its all-time high of $24.08 million, reached on January 31, 2018.
Performance
KALV Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
KALV Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.7% | -2.8% |
| 3 y3 years | +133.3% | +119.1% |
| 5 y5 years | +26.3% | +111.7% |
KALV Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +133.3% | -2.8% | +129.7% |
| 5 y | 5-year | at high | +195.4% | -2.8% | +240.0% |
| alltime | all time | -1.8% | +655.7% | -8.0% | +1072.1% |
KalVista Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $22.16 M(-1.1%) |
| Jul 2024 | - | $22.41 M(-1.7%) |
| Apr 2024 | $22.81 M(+51.7%) | $22.81 M(+19.2%) |
| Jan 2024 | - | $19.13 M(+7.8%) |
| Oct 2023 | - | $17.75 M(+25.6%) |
| Jul 2023 | - | $14.13 M(-6.0%) |
| Apr 2023 | $15.03 M(+29.9%) | $15.03 M(+29.5%) |
| Jan 2023 | - | $11.61 M(+2.5%) |
| Oct 2022 | - | $11.32 M(+16.3%) |
| Jul 2022 | - | $9.73 M(-15.9%) |
| Apr 2022 | - | $11.58 M(+20.0%) |
| Apr 2022 | $11.58 M(+18.4%) | - |
| Jan 2022 | - | $9.65 M(-4.6%) |
| Oct 2021 | - | $10.11 M(+22.9%) |
| Jul 2021 | - | $8.23 M(-15.8%) |
| Apr 2021 | $9.77 M(+26.6%) | $9.77 M(+50.0%) |
| Jan 2021 | - | $6.52 M(-31.6%) |
| Oct 2020 | - | $9.54 M(+12.8%) |
| Jul 2020 | - | $8.46 M(+9.5%) |
| Apr 2020 | $7.72 M | $7.72 M(-20.9%) |
| Jan 2020 | - | $9.76 M(-6.8%) |
| Oct 2019 | - | $10.47 M(-25.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2019 | - | $13.97 M(-22.6%) |
| Apr 2019 | $18.05 M(-22.2%) | $18.05 M(-4.1%) |
| Jan 2019 | - | $18.83 M(-10.1%) |
| Oct 2018 | - | $20.94 M(-8.6%) |
| Jul 2018 | - | $22.90 M(-1.3%) |
| Apr 2018 | $23.22 M(+669.3%) | $23.22 M(-3.6%) |
| Jan 2018 | - | $24.08 M(+585.5%) |
| Oct 2017 | - | $3.51 M(-8.4%) |
| Jul 2017 | - | $3.84 M(+27.1%) |
| Apr 2017 | $3.02 M(-7.1%) | $3.02 M(-5.7%) |
| Jan 2017 | - | $3.20 M(+69.3%) |
| Sep 2016 | - | $1.89 M(-2.0%) |
| Jun 2016 | - | $1.93 M(-49.9%) |
| Apr 2016 | $3.25 M(-23.9%) | - |
| Mar 2016 | - | $3.85 M(-9.8%) |
| Dec 2015 | $4.27 M(-39.8%) | $4.27 M(+12.6%) |
| Sep 2015 | - | $3.79 M(-9.0%) |
| Jun 2015 | - | $4.17 M(-62.1%) |
| Mar 2015 | - | $11.01 M(+55.2%) |
| Dec 2014 | $7.09 M(+79.6%) | $7.09 M(-6.2%) |
| Sep 2014 | - | $7.56 M(+91.5%) |
| Dec 2013 | $3.95 M(+28.7%) | $3.95 M |
| Dec 2012 | $3.07 M | - |
FAQ
- What is KalVista Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual current liabilities year-on-year change?
- What is KalVista Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly current liabilities year-on-year change?
What is KalVista Pharmaceuticals annual total current liabilities?
The current annual current liabilities of KALV is $22.81 M
What is the all time high annual current liabilities for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual total current liabilities is $23.22 M
What is KalVista Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, KALV annual total current liabilities has changed by +$7.78 M (+51.72%)
What is KalVista Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of KALV is $22.16 M
What is the all time high quarterly current liabilities for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly total current liabilities is $24.08 M
What is KalVista Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, KALV quarterly total current liabilities has changed by -$643.00 K (-2.82%)